BCLI
Brainstorm Cell Therapeutics Inc.Company with tickers: BCLI
CIK
1137883
CUSIP
10501E300
Shares Outstanding
11,034,775
Website
https://www.brainstorm-cell.com
Investor Relations
https://brainstorm-cell.com/investors/
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-25 | Pitts Peter Joe |
Director | Other | 0 |
| 2026-02-26 | Lebovits Chaim |
President & CEO | Award | 1,800,000 |
| 2026-02-26 | Dagher Ibrahim B. |
Chief Medical Officer | Award | 225,000 |
| 2026-02-26 | Patlis Alla |
See Remarks | Award | 100,000 |
| 2026-02-26 | Lindborg Stacy |
Director, President and CEO | Award | 150,000 |
| 2026-02-26 | Polverino Anthony J. |
Director | Award | 150,000 |
| 2026-02-26 | Bairu Menghisteab |
Director | Award | 150,000 |
| 2026-02-26 | Naor Nir |
CFO | Award | 180,000 |
| 2026-02-26 | FRENKEL JACOB A |
Director | Award | 200,000 |
| 2026-02-26 | ARBEL IRIT |
Director | Award | 120,000 |
| 2026-02-26 | Yablonka Uri |
Director, EVP & Chief Business Officer | Award | 150,000 |
| 2026-02-26 | HARTOUNIAN HARTOUN |
EVP, Chief Operating Officer | Award | 225,000 |
| 2025-01-01 | Bairu Menghisteab |
Director | Award | 24,000 |
| 2025-01-01 | Dagher Ibrahim B. |
Chief Medical Officer | Award | 50,000 |
| 2025-01-01 | HARTOUNIAN HARTOUN |
EVP, Chief Operating Officer | Award | 50,000 |
| 2025-01-01 | Lebovits Chaim |
President & CEO | Award | 120,000 |
| 2025-01-01 | Yablonka Uri |
Director, EVP & Chief Business Officer | Award | 40,000 |
| 2025-01-01 | ARBEL IRIT |
Director | Award | 30,666 |
| 2025-01-01 | Dagher Ibrahim B. |
Chief Medical Officer | Other | 2,000 |
| 2025-01-01 | Patlis Alla |
See Remarks | Award | 40,000 |
| 2025-01-01 | Lindborg Stacy |
Director, President and CEO | Award | 20,000 |
| 2025-01-01 | Yablonka Uri |
Director, EVP & Chief Business Officer | Award | 20,000 |
| 2025-01-01 | Naor Nir |
CFO | Award | 30,666 |
| 2025-01-01 | FRENKEL JACOB A |
Director | Award | 40,000 |
| 2025-01-01 | Dagher Ibrahim B. |
Chief Medical Officer | Other | 10,666 |
| 2025-01-01 | Lebovits Chaim |
President & CEO | Other | 133,389 |
| 2025-01-01 | Polverino Anthony J. |
Director | Award | 24,000 |
| 2024-10-01 | Lebovits Chaim |
President & CEO | Buy | 1,836 |
| 2024-09-30 | Lebovits Chaim |
President & CEO | Other | 133,389 |
| 2024-09-30 | Lebovits Chaim |
President & CEO | Buy | 22,000 |
| 2024-07-19 | Dagher Ibrahim B. |
Chief Medical Officer | Sell | 63,000 |
| 2024-07-19 | Dagher Ibrahim B. |
Chief Medical Officer | Other | 30,000 |
| 2024-07-19 | Dagher Ibrahim B. |
Chief Medical Officer | Other | 160,000 |
| 2024-06-24 | HARTOUNIAN HARTOUN |
EVP, Chief Operating Officer | Award | 30,000 |
| 2024-06-24 | HARTOUNIAN HARTOUN |
EVP, Chief Operating Officer | Award | 60,000 |
| 2024-06-24 | HARTOUNIAN HARTOUN |
EVP, Chief Operating Officer | Other | 0 |
| 2024-05-28 | Lebovits Chaim |
President & CEO | Award | 15,000 |
| 2024-05-28 | Lebovits Chaim |
President & CEO | Other | 2,000,847 |
| 2024-05-22 | Lebovits Chaim |
President & CEO | Award | 25,000 |
| 2024-05-21 | Lebovits Chaim |
President & CEO | Other | 2,000,847 |
| 2024-05-21 | Lebovits Chaim |
President & CEO | Award | 25,000 |
| 2024-05-13 | Lebovits Chaim |
President & CEO | Award | 10,000 |
| 2024-05-11 | Lebovits Chaim |
President & CEO | Award | 10,000 |
| 2024-05-10 | Lebovits Chaim |
President & CEO | Other | 2,000,847 |
| 2024-05-10 | Lebovits Chaim |
President & CEO | Award | 20,000 |
| 2024-05-07 | Lebovits Chaim |
President & CEO | Other | 2,000,847 |
| 2024-05-07 | Lebovits Chaim |
President & CEO | Award | 66,300 |
| 2024-05-06 | Lebovits Chaim |
President & CEO | Award | 135,000 |
| 2024-05-06 | Lebovits Chaim |
President & CEO | Other | 2,000,847 |
| 2024-04-19 | Lebovits Chaim |
President & CEO | Award | 15,000 |
Showing 1–50 of 134 transactions